Article
DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications
1 Jan 2025
Abstract excerpt
BACKGROUND: Prostate cancer is a common cancer with a variable prognosis. Its management is currently guided by histological and biological markers such as the Gleason score and PSA. Developments in molecular biology are now making it possible to identify new targets for better classification of prostate cancer. Among emerging biomarker, DNA methylation, an epigenetic process, is increasingly being studied in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
